Improving how cells take in therapeutic materials
Cell membrane disruption and recovery for intracellular delivery
['FUNDING_OTHER'] · UNIVERSITY OF COLORADO · NIH-11075342
This study is exploring a new way to help medicines get into cells more easily, which could make treatments for various health conditions work better and be more effective for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF COLORADO (nih funded) |
| Locations | 1 site (Boulder, UNITED STATES) |
| Trial ID | NIH-11075342 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the delivery of therapeutic materials into cells, which is crucial for effective biological treatments. The approach involves disrupting cell membranes in a controlled manner to allow for the entry of various substances, overcoming limitations of traditional methods. By developing techniques that enable rapid and reversible membrane disruption, the research aims to improve the efficiency and viability of cell therapies. This could lead to better outcomes in biological experiments and therapeutic applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may benefit from advanced cell therapies or treatments that require efficient intracellular delivery of therapeutic agents.
Not a fit: Patients who are not seeking or do not require cell-based therapies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the effectiveness of cell-based therapies and treatments for various diseases.
How similar studies have performed: Previous research has shown promise in membrane disruption techniques for intracellular delivery, indicating potential for success in this novel approach.
Where this research is happening
Boulder, UNITED STATES
- UNIVERSITY OF COLORADO — Boulder, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DING, XIAOYUN — UNIVERSITY OF COLORADO
- Study coordinator: DING, XIAOYUN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.